TY - JOUR
T1 - Nonsurgical periodontal treatment in type II diabetics in a middle-income country
T2 - a cost-effectiveness analysis
AU - Rojas-Gómez, Ana M.
AU - Serrano, Juan J.
AU - Rosselli, Diego
PY - 2022/9/28
Y1 - 2022/9/28
N2 - OBJECTIVES: To evaluate the cost-effectiveness of the nonsurgical periodontal treatment (NSPT) compared with supragingival therapy in type II diabetics with periodontitis. METHODS: A decision tree analysis was used to estimate the costs and health outcomes of two periodontal therapies in a hypothetical cohort of type II diabetics with periodontitis. The analysis was developed from the perspective of a third-party payer at 1 year and 5 years. Probabilities were derived from two systematic reviews. The costs and resource use were validated by a Delphi expert panel. All costs were expressed in USD, using the 25 May 2021 Colombian pesos market exchange rate (USD 1 = COP 3,350). RESULTS: NSPT was a dominant alternative compared with subsidized supragingival therapy in type II diabetics with periodontitis, generating savings of USD 87 and 400, during the first year or up to 5 years, respectively, and improving dental survival from 32 to 69 percent. CONCLUSIONS: NSPT can generate savings by reducing the complications derived from uncontrolled periodontitis and tooth loss.
AB - OBJECTIVES: To evaluate the cost-effectiveness of the nonsurgical periodontal treatment (NSPT) compared with supragingival therapy in type II diabetics with periodontitis. METHODS: A decision tree analysis was used to estimate the costs and health outcomes of two periodontal therapies in a hypothetical cohort of type II diabetics with periodontitis. The analysis was developed from the perspective of a third-party payer at 1 year and 5 years. Probabilities were derived from two systematic reviews. The costs and resource use were validated by a Delphi expert panel. All costs were expressed in USD, using the 25 May 2021 Colombian pesos market exchange rate (USD 1 = COP 3,350). RESULTS: NSPT was a dominant alternative compared with subsidized supragingival therapy in type II diabetics with periodontitis, generating savings of USD 87 and 400, during the first year or up to 5 years, respectively, and improving dental survival from 32 to 69 percent. CONCLUSIONS: NSPT can generate savings by reducing the complications derived from uncontrolled periodontitis and tooth loss.
KW - cost-effectiveness analysis
KW - diabetes
KW - non-surgical periodontal treatment
KW - periodontal therapy
KW - periodontitis
UR - http://www.scopus.com/inward/record.url?scp=85138877994&partnerID=8YFLogxK
U2 - 10.1017/S0266462322000563
DO - 10.1017/S0266462322000563
M3 - Article
C2 - 36169019
AN - SCOPUS:85138877994
SN - 1471-6348
VL - 38
SP - e73
JO - International journal of technology assessment in health care
JF - International journal of technology assessment in health care
IS - 1
ER -
